Price $145.59 |
Market Cap
14.77B
|
Sector Health Care |
Div. Growth
7.00%
|
|
P/E
20.1
|
P/B
2.33
|
P/S
1.61
|
Dividend %
2.10%
|
|
P/CF
-
|
P/FCF
53.5
|
Op. Cash Flow
1.08M
|
FCF
2.5
|
|
Op. Margin
12.20%
|
Net Margin
8.20%
|
ROE
12.30%
|
ROI
11.70%
|
|
ROA
5.80%
|
EPS Growth
-35.10%
|
Current Ratio
1.2
|
Debt/Equity
67.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.29 | - | - | 1.6M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $14.82 | - | - | 1.19B | Strong Buy |
| PetIQ Inc (PETQ) | $21.37 | - | - | 564.3M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.96 | - | - | 18.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
